The program will increase diversity in clinical trials.
Trustee Susan G. Kornstein, M.D., shares how she became involved with the foundation, the inspiration behind her work and her plans to continue advancing women's health research.
After discovering new insights on how certain tumors respond better to treatment, two VCU researchers are breathing new life into a platinum-based drug to treat cancers resistant to available therapies.
A consortium of Central Virginia institutions rich in history and expertise has come together to establish the region as a national leader in physical rehabilitation care and research.
One patient who was paralyzed in 2013 after a combat-related seizure led to a fall is now participating in a clinical trial to improve his mobility and health.
Cecil Hamlett shares his experience amyloidosis and how the correct diagnosis and heart transplant at VCU Health saved his life.
Tom Cardwell's perspective on learning about his amyloidosis diagnosis and how treatments at VCU Health have given him his energy back.
A once rare disease, Amyloidosis is now much more prevalent, and VCU Health is a global leader in research and treatment.
VCU’s Medicines for All Institute (M4ALL) has improved the world’s ability to fight COVID-19 by rethinking how drugs are made and expanding access globally.
A new scholarly book edited by the CEO of VCU Health System discusses how combat casualty care has transformed and saved lives on and off the battlefield.
One VCU Health researcher is leading a global effort to better understand the essential role the liver plays in overall health and how a significant portion of the U.S. and global population is at risk for liver disease.
A $1.5 million grant establishes a new program focusing on prenatal maternal health in Richmond and rural communities in Virginia.
Your generosity inspires innovation, encourages excellence and transforms dreams into discoveries. Discover your great place in the VCU Health community.
Giving
